詳細検索

詳細検索

お問い合わせ

Global Pharmaceutical Track and Trace Solutions Market Outlook, InDepth Analysis & Forecast to 2032

Global Pharmaceutical Track and Trace Solutions Market Outlook, InDepth Analysis & Forecast to 2032


医薬品トラック&トレースソリューションの世界市場 2026-2032年

The global Pharmaceutical Track and Trace Solutions market is projected to grow from US$ 6850 million in 2025 to US$ 13868 million by 2032, at a CAGR of 10.6% (2026-2032), driven by critical produc... もっと見る

 

 

出版社
QYResearch
QYリサーチ
出版年月
2026年11月15日
電子版価格
US$4,900
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
5-7営業日
言語
英語

英語原文をAIを使って翻訳しています。


 

お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る



図表リスト

List of Tables
Table 1. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Deployment Model, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Annual Serialized Units, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Pharmaceutical Track and Trace Solutions Revenue by Region (US$ Million), 2021-2026
Table 7. Global Pharmaceutical Track and Trace Solutions Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Pharmaceutical Track and Trace Solutions Revenue by Players (US$ Million), 2021-2026
Table 10. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical Track and Trace Solutions Revenue, 2025
Table 13. Global Pharmaceutical Track and Trace Solutions Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Pharmaceutical Track and Trace Solutions Companies Headquarters
Table 15. Global Pharmaceutical Track and Trace Solutions Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Pharmaceutical Track and Trace Solutions Revenue by Type (US$ Million), 2021-2026
Table 19. Global Pharmaceutical Track and Trace Solutions Revenue by Type (US$ Million), 2027-2032
Table 20. Global Pharmaceutical Track and Trace Solutions Revenue by Deployment Model (US$ Million), 2021-2026
Table 21. Global Pharmaceutical Track and Trace Solutions Revenue by Deployment Model (US$ Million), 2027-2032
Table 22. Global Pharmaceutical Track and Trace Solutions Revenue by Annual Serialized Units (US$ Million), 2021-2026
Table 23. Global Pharmaceutical Track and Trace Solutions Revenue by Annual Serialized Units (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Pharmaceutical Track and Trace Solutions Revenue by Application (US$ Million), 2021-2026
Table 26. Global Pharmaceutical Track and Trace Solutions Revenue by Application (US$ Million), 2027-2032
Table 27. Pharmaceutical Track and Trace Solutions High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 31. North America Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 33. Europe Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Pharmaceutical Track and Trace Solutions Investment Opportunities and Key Challenges
Table 37. Central and South America Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Pharmaceutical Track and Trace Solutions Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. TraceLink Inc. Corporation Information
Table 41. TraceLink Inc. Description and Major Businesses
Table 42. TraceLink Inc. Product Features and Attributes
Table 43. TraceLink Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. TraceLink Inc. Revenue Proportion by Product in 2025
Table 45. TraceLink Inc. Revenue Proportion by Application in 2025
Table 46. TraceLink Inc. Revenue Proportion by Geographic Area in 2025
Table 47. TraceLink Inc. Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 48. TraceLink Inc. Recent Developments
Table 49. SAP SE Corporation Information
Table 50. SAP SE Description and Major Businesses
Table 51. SAP SE Product Features and Attributes
Table 52. SAP SE Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. SAP SE Revenue Proportion by Product in 2025
Table 54. SAP SE Revenue Proportion by Application in 2025
Table 55. SAP SE Revenue Proportion by Geographic Area in 2025
Table 56. SAP SE Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 57. SAP SE Recent Developments
Table 58. Antares Vision Group Corporation Information
Table 59. Antares Vision Group Description and Major Businesses
Table 60. Antares Vision Group Product Features and Attributes
Table 61. Antares Vision Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Antares Vision Group Revenue Proportion by Product in 2025
Table 63. Antares Vision Group Revenue Proportion by Application in 2025
Table 64. Antares Vision Group Revenue Proportion by Geographic Area in 2025
Table 65. Antares Vision Group Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 66. Antares Vision Group Recent Developments
Table 67. OPTEL Group Corporation Information
Table 68. OPTEL Group Description and Major Businesses
Table 69. OPTEL Group Product Features and Attributes
Table 70. OPTEL Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. OPTEL Group Revenue Proportion by Product in 2025
Table 72. OPTEL Group Revenue Proportion by Application in 2025
Table 73. OPTEL Group Revenue Proportion by Geographic Area in 2025
Table 74. OPTEL Group Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 75. OPTEL Group Recent Developments
Table 76. Systech International (Markem-Imaje) Corporation Information
Table 77. Systech International (Markem-Imaje) Description and Major Businesses
Table 78. Systech International (Markem-Imaje) Product Features and Attributes
Table 79. Systech International (Markem-Imaje) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Systech International (Markem-Imaje) Revenue Proportion by Product in 2025
Table 81. Systech International (Markem-Imaje) Revenue Proportion by Application in 2025
Table 82. Systech International (Markem-Imaje) Revenue Proportion by Geographic Area in 2025
Table 83. Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 84. Systech International (Markem-Imaje) Recent Developments
Table 85. Körber AG Corporation Information
Table 86. Körber AG Description and Major Businesses
Table 87. Körber AG Product Features and Attributes
Table 88. Körber AG Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Körber AG Recent Developments
Table 90. SEA Vision Corporation Information
Table 91. SEA Vision Description and Major Businesses
Table 92. SEA Vision Product Features and Attributes
Table 93. SEA Vision Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. SEA Vision Recent Developments
Table 95. WIPOTEC GmbH Corporation Information
Table 96. WIPOTEC GmbH Description and Major Businesses
Table 97. WIPOTEC GmbH Product Features and Attributes
Table 98. WIPOTEC GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. WIPOTEC GmbH Recent Developments
Table 100. Domino Printing Sciences Corporation Information
Table 101. Domino Printing Sciences Description and Major Businesses
Table 102. Domino Printing Sciences Product Features and Attributes
Table 103. Domino Printing Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Domino Printing Sciences Recent Developments
Table 105. Videojet Technologies Corporation Information
Table 106. Videojet Technologies Description and Major Businesses
Table 107. Videojet Technologies Product Features and Attributes
Table 108. Videojet Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Videojet Technologies Recent Developments
Table 110. Arvato Systems Corporation Information
Table 111. Arvato Systems Description and Major Businesses
Table 112. Arvato Systems Product Features and Attributes
Table 113. Arvato Systems Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Arvato Systems Recent Developments
Table 115. SoftGroup AD Corporation Information
Table 116. SoftGroup AD Description and Major Businesses
Table 117. SoftGroup AD Product Features and Attributes
Table 118. SoftGroup AD Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. SoftGroup AD Recent Developments
Table 120. tracekey solutions GmbH Corporation Information
Table 121. tracekey solutions GmbH Description and Major Businesses
Table 122. tracekey solutions GmbH Product Features and Attributes
Table 123. tracekey solutions GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. tracekey solutions GmbH Recent Developments
Table 125. LSPedia Inc. Corporation Information
Table 126. LSPedia Inc. Description and Major Businesses
Table 127. LSPedia Inc. Product Features and Attributes
Table 128. LSPedia Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. LSPedia Inc. Recent Developments
Table 130. Covectra, Inc. Corporation Information
Table 131. Covectra, Inc. Description and Major Businesses
Table 132. Covectra, Inc. Product Features and Attributes
Table 133. Covectra, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. Covectra, Inc. Recent Developments
Table 135. ACG Inspection Corporation Information
Table 136. ACG Inspection Description and Major Businesses
Table 137. ACG Inspection Product Features and Attributes
Table 138. ACG Inspection Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. ACG Inspection Recent Developments
Table 140. Laetus GmbH Corporation Information
Table 141. Laetus GmbH Description and Major Businesses
Table 142. Laetus GmbH Product Features and Attributes
Table 143. Laetus GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Laetus GmbH Recent Developments
Table 145. Vimachem Corporation Information
Table 146. Vimachem Description and Major Businesses
Table 147. Vimachem Product Features and Attributes
Table 148. Vimachem Revenue (US$ Million) and Gross Margin (2021-2026)
Table 149. Vimachem Recent Developments
Table 150. Movilitas Corporation Information
Table 151. Movilitas Description and Major Businesses
Table 152. Movilitas Product Features and Attributes
Table 153. Movilitas Revenue (US$ Million) and Gross Margin (2021-2026)
Table 154. Movilitas Recent Developments
Table 155. Kezzler AS Corporation Information
Table 156. Kezzler AS Description and Major Businesses
Table 157. Kezzler AS Product Features and Attributes
Table 158. Kezzler AS Revenue (US$ Million) and Gross Margin (2021-2026)
Table 159. Kezzler AS Recent Developments
Table 160. Nippon Express Holdings, Inc. Corporation Information
Table 161. Nippon Express Holdings, Inc. Description and Major Businesses
Table 162. Nippon Express Holdings, Inc. Product Features and Attributes
Table 163. Nippon Express Holdings, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 164. Nippon Express Holdings, Inc. Recent Developments
Table 165. Sinotrans Limited Corporation Information
Table 166. Sinotrans Limited Description and Major Businesses
Table 167. Sinotrans Limited Product Features and Attributes
Table 168. Sinotrans Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 169. Sinotrans Limited Recent Developments
Table 170. Shenzhen SINO-MD Information Technology Co., Ltd. Corporation Information
Table 171. Shenzhen SINO-MD Information Technology Co., Ltd. Description and Major Businesses
Table 172. Shenzhen SINO-MD Information Technology Co., Ltd. Product Features and Attributes
Table 173. Shenzhen SINO-MD Information Technology Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 174. Shenzhen SINO-MD Information Technology Co., Ltd. Recent Developments
Table 175. Technologies, Platforms and Infrastructure
Table 176. Distributors List
Table 177. Market Trends and Market Evolution
Table 178. Market Drivers and Opportunities
Table 179. Market Challenges, Risks, and Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List of Figures
Figure 1. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Barcode/2D Code Product Picture
Figure 3. RFID Product Picture
Figure 4. Hybrid Identification Product Picture
Figure 5. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Deployment Model, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Cloud-Based Product Picture
Figure 7. On-Premises Product Picture
Figure 8. Hybrid Product Picture
Figure 9. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Annual Serialized Units, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Low Annual Serialized Units(≤10 million units) Product Picture
Figure 11. Medium Annual Serialized Units(10 million units<Annual Serialized Units≤100 million units) Product Picture
Figure 12. High Annual Serialized Units(>100 million units) Product Picture
Figure 13. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Serialization and Coding
Figure 15. Supply Chain Traceability
Figure 16. Recall and Verification
Figure 17. Other
Figure 18. Pharmaceutical Track and Trace Solutions Report Years Considered
Figure 19. Global Pharmaceutical Track and Trace Solutions Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 21. Global Pharmaceutical Track and Trace Solutions Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share Ranking (2025)
Figure 24. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 25. Barcode/2D Code Revenue-Based Market Share by Player in 2025
Figure 26. RFID Revenue-Based Market Share by Player in 2025
Figure 27. Hybrid Identification Revenue-Based Market Share by Player in 2025
Figure 28. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Type (2021-2032)
Figure 29. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Deployment Model (2021-2032)
Figure 30. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Annual Serialized Units (2021-2032)
Figure 31. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Application (2021-2032)
Figure 32. North America Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 33. North America Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 34. North America Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 35. US Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 36. Canada Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 37. Mexico Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 38. Europe Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 39. Europe Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 40. Europe Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 41. Germany Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 42. France Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 43. U.K. Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 44. Italy Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 45. Russia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 46. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 47. Asia-Pacific Top 8 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 48. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 49. Indonesia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 50. Japan Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 51. South Korea Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 52. Australia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 53. India Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 54. Indonesia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 55. Vietnam Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 56. Malaysia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 57. Philippines Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 58. Singapore Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 59. Central and South America Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 60. Central and South America Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 61. Central and South America Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 62. Brazil Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 63. Argentina Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 64. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 65. Middle East and Africa Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 66. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 67. GCC Countries Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 68. Israel Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 69. Egypt Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 70. South Africa Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 71. Pharmaceutical Track and Trace Solutions Value Chain Mapping
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

 

ページTOPに戻る


 

Summary

The global Pharmaceutical Track and Trace Solutions market is projected to grow from US$ 6850 million in 2025 to US$ 13868 million by 2032, at a CAGR of 10.6% (2026-2032), driven by critical product segments and diverse end‑use applications.

Pharmaceutical Track and Trace Solutions are integrated hardware, software, and service systems designed to identify, serialize, monitor, and verify pharmaceutical products throughout the supply chain. These solutions typically include serialization software, coding and marking equipment, machine vision inspection, aggregation systems, traceability databases, and supply chain data exchange platforms. Key capabilities include unique product identification, batch and serial number management, packaging hierarchy aggregation, transaction event recording, product authentication, and regulatory reporting. Major applications include pharmaceutical manufacturing, contract packaging, wholesale distribution, logistics, hospital pharmacies, and retail pharmacy networks.

Key Findings
Gross margins of major Pharmaceutical Track and Trace Solutions providers were estimated at approximately 35%–55%
The global Pharmaceutical Track and Trace Solutions market is primarily driven by pharmaceutical serialization regulations and supply chain transparency requirements
Serialization software, coding and inspection equipment, aggregation systems, and data exchange platforms are the core components of Pharmaceutical Track and Trace Solutions
Software subscriptions, system maintenance, regulatory updates, and technical support generate recurring revenue for Pharmaceutical Track and Trace Solutions providers
Pharmaceutical manufacturers, contract packaging organizations, and wholesale distributors are the primary customers for Pharmaceutical Track and Trace Solutions
Cloud-based traceability, interoperability, and real-time supply chain visibility are major development priorities for Pharmaceutical Track and Trace Solutions

Market Trends
Pharmaceutical Track and Trace Solutions are evolving from individual production-line serialization systems toward integrated enterprise and supply chain traceability platforms. Manufacturers are increasingly connecting packaging equipment, enterprise serialization software, warehouse management systems, and external trading partners through standardized data exchange architectures. Cloud-based platforms are gaining adoption because they simplify multi-site deployment, regulatory updates, and partner connectivity. GS1 identification standards and EPCIS-based event data exchange are important foundations for interoperability. Advanced analytics, automated exception handling, and real-time product verification are becoming increasingly important as pharmaceutical supply chains become more complex.

Market Dynamics
Pharmaceutical Track and Trace Solutions demand is influenced by national serialization regulations, pharmaceutical production volumes, packaging line modernization, and supply chain digitization. The market includes serialization software licenses, cloud subscriptions, coding and marking hardware, inspection systems, aggregation equipment, implementation services, and ongoing technical support. Large pharmaceutical manufacturers typically require enterprise-wide platforms supporting multiple production sites and international markets, while smaller manufacturers and contract packaging companies often prioritize modular solutions with lower initial investment. Regulatory deadlines can accelerate purchasing, although project timing depends on technical readiness and trading partner integration. Hardware replacement cycles and software maintenance contracts create different revenue patterns.

Drivers
Stricter pharmaceutical traceability regulations, increasing efforts to prevent counterfeit medicines, demand for supply chain transparency, and growing pharmaceutical manufacturing complexity are the main drivers of Pharmaceutical Track and Trace Solutions adoption. The United States Drug Supply Chain Security Act, European Union Falsified Medicines Directive framework, and national traceability initiatives in other markets support investment in serialization and verification infrastructure. Pharmaceutical companies also use traceability data to improve recall execution, inventory control, and distribution accountability.

Restraints
Pharmaceutical Track and Trace Solutions face substantial implementation costs, complex integration with legacy manufacturing systems, and differences in regulatory requirements across countries. Data interoperability challenges, packaging line downtime during upgrades, and ongoing maintenance obligations can increase total ownership costs. Smaller pharmaceutical companies may experience financial and technical constraints when implementing enterprise-level traceability systems.

Opportunities
Pharmaceutical production line upgrades, contract manufacturing expansion, specialty medicine distribution, biologics, cold-chain pharmaceuticals, and cross-border drug supply chains create opportunities for advanced Pharmaceutical Track and Trace Solutions. Cloud-based serialization services, standardized partner connectivity, automated regulatory reporting, and integrated product authentication provide additional differentiation potential. Expansion of pharmaceutical traceability requirements in emerging markets offers further growth opportunities.

Challenges
Pharmaceutical Track and Trace Solutions providers must maintain reliable serial number management, accurate packaging aggregation, secure data transmission, and high system availability. Managing inconsistent data formats, large transaction volumes, regulatory changes, and integration with enterprise resource planning and warehouse management systems remains technically demanding. Cybersecurity, data integrity, system validation, and business continuity are essential for pharmaceutical supply chain applications.

Segment Insights
Pharmaceutical Track and Trace Solutions can be differentiated by technology, deployment model, and application. Hardware solutions include coding equipment, machine vision inspection systems, and aggregation devices. Software solutions include line-level serialization management, site-level control, enterprise traceability platforms, and supply chain data exchange systems. Cloud deployments emphasize scalability and partner connectivity, while on-premises installations address selected security and infrastructure requirements. Pharmaceutical manufacturers prioritize production integration and regulatory compliance, whereas distributors and pharmacies emphasize product verification and transaction visibility.

Downstream Market Opportunities
Branded pharmaceutical manufacturers, generic drug producers, biotechnology companies, contract development and manufacturing organizations, pharmaceutical packaging providers, wholesale distributors, logistics operators, hospitals, and pharmacy chains represent the main downstream markets for Pharmaceutical Track and Trace Solutions. Continued regulatory implementation, expansion of international pharmaceutical trade, and demand for more transparent distribution networks provide opportunities for integrated traceability technology providers. Long-term software maintenance, cloud subscriptions, system upgrades, and partner onboarding services support recurring business opportunities.

Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Pharmaceutical Track and Trace Solutions market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
TraceLink Inc.
SAP SE
Antares Vision Group
OPTEL Group
Systech International (Markem-Imaje)
Körber AG
SEA Vision
WIPOTEC GmbH
Domino Printing Sciences
Videojet Technologies
Arvato Systems
SoftGroup AD
tracekey solutions GmbH
LSPedia Inc.
Covectra, Inc.
ACG Inspection
Laetus GmbH
Vimachem
Movilitas
Kezzler AS
Nippon Express Holdings, Inc.
Sinotrans Limited
Shenzhen SINO-MD Information Technology Co., Ltd.

Segment by Type
Barcode/2D Code
RFID
Hybrid Identification

Segment by Deployment Model
Cloud-Based
On-Premises
Hybrid

Segment by Annual Serialized Units
Low Annual Serialized Units(≤10 million units)
Medium Annual Serialized Units(10 million units<Annual Serialized Units≤100 million units)
High Annual Serialized Units(>100 million units)

Segment by Application
Serialization and Coding
Supply Chain Traceability
Recall and Verification
Other

Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA

Chapter Outline
Chapter 1: Defines the Pharmaceutical Track and Trace Solutions study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.

Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Introduction to Pharmaceutical Track and Trace Solutions: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Track and Trace Solutions Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Barcode/2D Code
1.2.3 RFID
1.2.4 Hybrid Identification
1.3 Market Segmentation by Deployment Model
1.3.1 Global Pharmaceutical Track and Trace Solutions Market Size by Deployment Model, 2021 vs 2025 vs 2032
1.3.2 Cloud-Based
1.3.3 On-Premises
1.3.4 Hybrid
1.4 Market Segmentation by Annual Serialized Units
1.4.1 Global Pharmaceutical Track and Trace Solutions Market Size by Annual Serialized Units, 2021 vs 2025 vs 2032
1.4.2 Low Annual Serialized Units(≤10 million units)
1.4.3 Medium Annual Serialized Units(10 million units<Annual Serialized Units≤100 million units)
1.4.4 High Annual Serialized Units(>100 million units)
1.5 Market Segmentation by Application
1.5.1 Global Pharmaceutical Track and Trace Solutions Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Serialization and Coding
1.5.3 Supply Chain Traceability
1.5.4 Recall and Verification
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Pharmaceutical Track and Trace Solutions Revenue Estimates and Forecasts (2021-2032)
2.2 Global Pharmaceutical Track and Trace Solutions Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape
3.1 Global Pharmaceutical Track and Trace Solutions Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Pharmaceutical Track and Trace Solutions Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Barcode/2D Code: Market Share by Key Players
3.3.2 RFID: Market Share by Key Players
3.3.3 Hybrid Identification: Market Share by Key Players
3.4 Global Pharmaceutical Track and Trace Solutions Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation
4.1 Global Pharmaceutical Track and Trace Solutions Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Pharmaceutical Track and Trace Solutions Market by Deployment Model
4.2.1 Global Revenue by Deployment Model (2021-2032)
4.2.2 Global Revenue-Based Market Share by Deployment Model (2021-2032)
4.3 Global Pharmaceutical Track and Trace Solutions Market by Annual Serialized Units
4.3.1 Global Revenue by Annual Serialized Units (2021-2032)
4.3.2 Global Revenue-Based Market Share by Annual Serialized Units (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Pharmaceutical Track and Trace Solutions Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Pharmaceutical Track and Trace Solutions Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Pharmaceutical Track and Trace Solutions Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico

7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Pharmaceutical Track and Trace Solutions Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Pharmaceutical Track and Trace Solutions Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Pharmaceutical Track and Trace Solutions Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Pharmaceutical Track and Trace Solutions Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Pharmaceutical Track and Trace Solutions Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Pharmaceutical Track and Trace Solutions Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Pharmaceutical Track and Trace Solutions Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Pharmaceutical Track and Trace Solutions Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 TraceLink Inc.
11.1.1 TraceLink Inc. Corporation Information
11.1.2 TraceLink Inc. Business Overview
11.1.3 TraceLink Inc. Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.1.4 TraceLink Inc. Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.1.5 TraceLink Inc. Pharmaceutical Track and Trace Solutions Revenue by Product in 2025
11.1.6 TraceLink Inc. Pharmaceutical Track and Trace Solutions Revenue by Application in 2025
11.1.7 TraceLink Inc. Pharmaceutical Track and Trace Solutions Revenue by Geographic Area in 2025
11.1.8 TraceLink Inc. Pharmaceutical Track and Trace Solutions SWOT Analysis
11.1.9 TraceLink Inc. Recent Developments
11.2 SAP SE
11.2.1 SAP SE Corporation Information
11.2.2 SAP SE Business Overview
11.2.3 SAP SE Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.2.4 SAP SE Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.2.5 SAP SE Pharmaceutical Track and Trace Solutions Revenue by Product in 2025
11.2.6 SAP SE Pharmaceutical Track and Trace Solutions Revenue by Application in 2025
11.2.7 SAP SE Pharmaceutical Track and Trace Solutions Revenue by Geographic Area in 2025
11.2.8 SAP SE Pharmaceutical Track and Trace Solutions SWOT Analysis
11.2.9 SAP SE Recent Developments
11.3 Antares Vision Group
11.3.1 Antares Vision Group Corporation Information
11.3.2 Antares Vision Group Business Overview
11.3.3 Antares Vision Group Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.3.4 Antares Vision Group Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.3.5 Antares Vision Group Pharmaceutical Track and Trace Solutions Revenue by Product in 2025
11.3.6 Antares Vision Group Pharmaceutical Track and Trace Solutions Revenue by Application in 2025
11.3.7 Antares Vision Group Pharmaceutical Track and Trace Solutions Revenue by Geographic Area in 2025
11.3.8 Antares Vision Group Pharmaceutical Track and Trace Solutions SWOT Analysis
11.3.9 Antares Vision Group Recent Developments
11.4 OPTEL Group
11.4.1 OPTEL Group Corporation Information
11.4.2 OPTEL Group Business Overview
11.4.3 OPTEL Group Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.4.4 OPTEL Group Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.4.5 OPTEL Group Pharmaceutical Track and Trace Solutions Revenue by Product in 2025
11.4.6 OPTEL Group Pharmaceutical Track and Trace Solutions Revenue by Application in 2025
11.4.7 OPTEL Group Pharmaceutical Track and Trace Solutions Revenue by Geographic Area in 2025
11.4.8 OPTEL Group Pharmaceutical Track and Trace Solutions SWOT Analysis
11.4.9 OPTEL Group Recent Developments
11.5 Systech International (Markem-Imaje)
11.5.1 Systech International (Markem-Imaje) Corporation Information
11.5.2 Systech International (Markem-Imaje) Business Overview
11.5.3 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.5.4 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.5.5 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions Revenue by Product in 2025
11.5.6 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions Revenue by Application in 2025
11.5.7 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions Revenue by Geographic Area in 2025
11.5.8 Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions SWOT Analysis
11.5.9 Systech International (Markem-Imaje) Recent Developments
11.6 Körber AG
11.6.1 Körber AG Corporation Information
11.6.2 Körber AG Business Overview
11.6.3 Körber AG Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.6.4 Körber AG Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.6.5 Körber AG Recent Developments
11.7 SEA Vision
11.7.1 SEA Vision Corporation Information
11.7.2 SEA Vision Business Overview
11.7.3 SEA Vision Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.7.4 SEA Vision Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.7.5 SEA Vision Recent Developments
11.8 WIPOTEC GmbH
11.8.1 WIPOTEC GmbH Corporation Information
11.8.2 WIPOTEC GmbH Business Overview
11.8.3 WIPOTEC GmbH Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.8.4 WIPOTEC GmbH Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.8.5 WIPOTEC GmbH Recent Developments
11.9 Domino Printing Sciences
11.9.1 Domino Printing Sciences Corporation Information
11.9.2 Domino Printing Sciences Business Overview
11.9.3 Domino Printing Sciences Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.9.4 Domino Printing Sciences Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.9.5 Domino Printing Sciences Recent Developments
11.10 Videojet Technologies
11.10.1 Videojet Technologies Corporation Information
11.10.2 Videojet Technologies Business Overview
11.10.3 Videojet Technologies Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.10.4 Videojet Technologies Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Arvato Systems
11.11.1 Arvato Systems Corporation Information
11.11.2 Arvato Systems Business Overview
11.11.3 Arvato Systems Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.11.4 Arvato Systems Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.11.5 Arvato Systems Recent Developments
11.12 SoftGroup AD
11.12.1 SoftGroup AD Corporation Information
11.12.2 SoftGroup AD Business Overview
11.12.3 SoftGroup AD Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.12.4 SoftGroup AD Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.12.5 SoftGroup AD Recent Developments
11.13 tracekey solutions GmbH
11.13.1 tracekey solutions GmbH Corporation Information
11.13.2 tracekey solutions GmbH Business Overview
11.13.3 tracekey solutions GmbH Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.13.4 tracekey solutions GmbH Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.13.5 tracekey solutions GmbH Recent Developments
11.14 LSPedia Inc.
11.14.1 LSPedia Inc. Corporation Information
11.14.2 LSPedia Inc. Business Overview
11.14.3 LSPedia Inc. Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.14.4 LSPedia Inc. Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.14.5 LSPedia Inc. Recent Developments
11.15 Covectra, Inc.
11.15.1 Covectra, Inc. Corporation Information
11.15.2 Covectra, Inc. Business Overview
11.15.3 Covectra, Inc. Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.15.4 Covectra, Inc. Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.15.5 Covectra, Inc. Recent Developments
11.16 ACG Inspection
11.16.1 ACG Inspection Corporation Information
11.16.2 ACG Inspection Business Overview
11.16.3 ACG Inspection Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.16.4 ACG Inspection Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.16.5 ACG Inspection Recent Developments
11.17 Laetus GmbH
11.17.1 Laetus GmbH Corporation Information
11.17.2 Laetus GmbH Business Overview
11.17.3 Laetus GmbH Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.17.4 Laetus GmbH Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.17.5 Laetus GmbH Recent Developments
11.18 Vimachem
11.18.1 Vimachem Corporation Information
11.18.2 Vimachem Business Overview
11.18.3 Vimachem Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.18.4 Vimachem Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.18.5 Vimachem Recent Developments
11.19 Movilitas
11.19.1 Movilitas Corporation Information
11.19.2 Movilitas Business Overview
11.19.3 Movilitas Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.19.4 Movilitas Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.19.5 Movilitas Recent Developments
11.20 Kezzler AS
11.20.1 Kezzler AS Corporation Information
11.20.2 Kezzler AS Business Overview
11.20.3 Kezzler AS Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.20.4 Kezzler AS Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.20.5 Kezzler AS Recent Developments
11.21 Nippon Express Holdings, Inc.
11.21.1 Nippon Express Holdings, Inc. Corporation Information
11.21.2 Nippon Express Holdings, Inc. Business Overview
11.21.3 Nippon Express Holdings, Inc. Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.21.4 Nippon Express Holdings, Inc. Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.21.5 Nippon Express Holdings, Inc. Recent Developments
11.22 Sinotrans Limited
11.22.1 Sinotrans Limited Corporation Information
11.22.2 Sinotrans Limited Business Overview
11.22.3 Sinotrans Limited Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.22.4 Sinotrans Limited Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.22.5 Sinotrans Limited Recent Developments
11.23 Shenzhen SINO-MD Information Technology Co., Ltd.
11.23.1 Shenzhen SINO-MD Information Technology Co., Ltd. Corporation Information
11.23.2 Shenzhen SINO-MD Information Technology Co., Ltd. Business Overview
11.23.3 Shenzhen SINO-MD Information Technology Co., Ltd. Pharmaceutical Track and Trace Solutions Product Features and Attributes
11.23.4 Shenzhen SINO-MD Information Technology Co., Ltd. Pharmaceutical Track and Trace Solutions Revenue and Gross Margin (2021-2026)
11.23.5 Shenzhen SINO-MD Information Technology Co., Ltd. Recent Developments

12 Pharmaceutical Track and Trace Solutions Value Chain and Ecosystem Analysis
12.1 Pharmaceutical Track and Trace Solutions Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Pharmaceutical Track and Trace Solutions Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Pharmaceutical Track and Trace Solutions Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Deployment Model, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Annual Serialized Units, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Pharmaceutical Track and Trace Solutions Revenue by Region (US$ Million), 2021-2026
Table 7. Global Pharmaceutical Track and Trace Solutions Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Pharmaceutical Track and Trace Solutions Revenue by Players (US$ Million), 2021-2026
Table 10. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical Track and Trace Solutions Revenue, 2025
Table 13. Global Pharmaceutical Track and Trace Solutions Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Pharmaceutical Track and Trace Solutions Companies Headquarters
Table 15. Global Pharmaceutical Track and Trace Solutions Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Pharmaceutical Track and Trace Solutions Revenue by Type (US$ Million), 2021-2026
Table 19. Global Pharmaceutical Track and Trace Solutions Revenue by Type (US$ Million), 2027-2032
Table 20. Global Pharmaceutical Track and Trace Solutions Revenue by Deployment Model (US$ Million), 2021-2026
Table 21. Global Pharmaceutical Track and Trace Solutions Revenue by Deployment Model (US$ Million), 2027-2032
Table 22. Global Pharmaceutical Track and Trace Solutions Revenue by Annual Serialized Units (US$ Million), 2021-2026
Table 23. Global Pharmaceutical Track and Trace Solutions Revenue by Annual Serialized Units (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Pharmaceutical Track and Trace Solutions Revenue by Application (US$ Million), 2021-2026
Table 26. Global Pharmaceutical Track and Trace Solutions Revenue by Application (US$ Million), 2027-2032
Table 27. Pharmaceutical Track and Trace Solutions High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 31. North America Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 33. Europe Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Pharmaceutical Track and Trace Solutions Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Pharmaceutical Track and Trace Solutions Investment Opportunities and Key Challenges
Table 37. Central and South America Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Pharmaceutical Track and Trace Solutions Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. TraceLink Inc. Corporation Information
Table 41. TraceLink Inc. Description and Major Businesses
Table 42. TraceLink Inc. Product Features and Attributes
Table 43. TraceLink Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. TraceLink Inc. Revenue Proportion by Product in 2025
Table 45. TraceLink Inc. Revenue Proportion by Application in 2025
Table 46. TraceLink Inc. Revenue Proportion by Geographic Area in 2025
Table 47. TraceLink Inc. Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 48. TraceLink Inc. Recent Developments
Table 49. SAP SE Corporation Information
Table 50. SAP SE Description and Major Businesses
Table 51. SAP SE Product Features and Attributes
Table 52. SAP SE Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. SAP SE Revenue Proportion by Product in 2025
Table 54. SAP SE Revenue Proportion by Application in 2025
Table 55. SAP SE Revenue Proportion by Geographic Area in 2025
Table 56. SAP SE Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 57. SAP SE Recent Developments
Table 58. Antares Vision Group Corporation Information
Table 59. Antares Vision Group Description and Major Businesses
Table 60. Antares Vision Group Product Features and Attributes
Table 61. Antares Vision Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Antares Vision Group Revenue Proportion by Product in 2025
Table 63. Antares Vision Group Revenue Proportion by Application in 2025
Table 64. Antares Vision Group Revenue Proportion by Geographic Area in 2025
Table 65. Antares Vision Group Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 66. Antares Vision Group Recent Developments
Table 67. OPTEL Group Corporation Information
Table 68. OPTEL Group Description and Major Businesses
Table 69. OPTEL Group Product Features and Attributes
Table 70. OPTEL Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. OPTEL Group Revenue Proportion by Product in 2025
Table 72. OPTEL Group Revenue Proportion by Application in 2025
Table 73. OPTEL Group Revenue Proportion by Geographic Area in 2025
Table 74. OPTEL Group Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 75. OPTEL Group Recent Developments
Table 76. Systech International (Markem-Imaje) Corporation Information
Table 77. Systech International (Markem-Imaje) Description and Major Businesses
Table 78. Systech International (Markem-Imaje) Product Features and Attributes
Table 79. Systech International (Markem-Imaje) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Systech International (Markem-Imaje) Revenue Proportion by Product in 2025
Table 81. Systech International (Markem-Imaje) Revenue Proportion by Application in 2025
Table 82. Systech International (Markem-Imaje) Revenue Proportion by Geographic Area in 2025
Table 83. Systech International (Markem-Imaje) Pharmaceutical Track and Trace Solutions SWOT Analysis
Table 84. Systech International (Markem-Imaje) Recent Developments
Table 85. Körber AG Corporation Information
Table 86. Körber AG Description and Major Businesses
Table 87. Körber AG Product Features and Attributes
Table 88. Körber AG Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Körber AG Recent Developments
Table 90. SEA Vision Corporation Information
Table 91. SEA Vision Description and Major Businesses
Table 92. SEA Vision Product Features and Attributes
Table 93. SEA Vision Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. SEA Vision Recent Developments
Table 95. WIPOTEC GmbH Corporation Information
Table 96. WIPOTEC GmbH Description and Major Businesses
Table 97. WIPOTEC GmbH Product Features and Attributes
Table 98. WIPOTEC GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. WIPOTEC GmbH Recent Developments
Table 100. Domino Printing Sciences Corporation Information
Table 101. Domino Printing Sciences Description and Major Businesses
Table 102. Domino Printing Sciences Product Features and Attributes
Table 103. Domino Printing Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Domino Printing Sciences Recent Developments
Table 105. Videojet Technologies Corporation Information
Table 106. Videojet Technologies Description and Major Businesses
Table 107. Videojet Technologies Product Features and Attributes
Table 108. Videojet Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Videojet Technologies Recent Developments
Table 110. Arvato Systems Corporation Information
Table 111. Arvato Systems Description and Major Businesses
Table 112. Arvato Systems Product Features and Attributes
Table 113. Arvato Systems Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Arvato Systems Recent Developments
Table 115. SoftGroup AD Corporation Information
Table 116. SoftGroup AD Description and Major Businesses
Table 117. SoftGroup AD Product Features and Attributes
Table 118. SoftGroup AD Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. SoftGroup AD Recent Developments
Table 120. tracekey solutions GmbH Corporation Information
Table 121. tracekey solutions GmbH Description and Major Businesses
Table 122. tracekey solutions GmbH Product Features and Attributes
Table 123. tracekey solutions GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. tracekey solutions GmbH Recent Developments
Table 125. LSPedia Inc. Corporation Information
Table 126. LSPedia Inc. Description and Major Businesses
Table 127. LSPedia Inc. Product Features and Attributes
Table 128. LSPedia Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. LSPedia Inc. Recent Developments
Table 130. Covectra, Inc. Corporation Information
Table 131. Covectra, Inc. Description and Major Businesses
Table 132. Covectra, Inc. Product Features and Attributes
Table 133. Covectra, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. Covectra, Inc. Recent Developments
Table 135. ACG Inspection Corporation Information
Table 136. ACG Inspection Description and Major Businesses
Table 137. ACG Inspection Product Features and Attributes
Table 138. ACG Inspection Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. ACG Inspection Recent Developments
Table 140. Laetus GmbH Corporation Information
Table 141. Laetus GmbH Description and Major Businesses
Table 142. Laetus GmbH Product Features and Attributes
Table 143. Laetus GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Laetus GmbH Recent Developments
Table 145. Vimachem Corporation Information
Table 146. Vimachem Description and Major Businesses
Table 147. Vimachem Product Features and Attributes
Table 148. Vimachem Revenue (US$ Million) and Gross Margin (2021-2026)
Table 149. Vimachem Recent Developments
Table 150. Movilitas Corporation Information
Table 151. Movilitas Description and Major Businesses
Table 152. Movilitas Product Features and Attributes
Table 153. Movilitas Revenue (US$ Million) and Gross Margin (2021-2026)
Table 154. Movilitas Recent Developments
Table 155. Kezzler AS Corporation Information
Table 156. Kezzler AS Description and Major Businesses
Table 157. Kezzler AS Product Features and Attributes
Table 158. Kezzler AS Revenue (US$ Million) and Gross Margin (2021-2026)
Table 159. Kezzler AS Recent Developments
Table 160. Nippon Express Holdings, Inc. Corporation Information
Table 161. Nippon Express Holdings, Inc. Description and Major Businesses
Table 162. Nippon Express Holdings, Inc. Product Features and Attributes
Table 163. Nippon Express Holdings, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 164. Nippon Express Holdings, Inc. Recent Developments
Table 165. Sinotrans Limited Corporation Information
Table 166. Sinotrans Limited Description and Major Businesses
Table 167. Sinotrans Limited Product Features and Attributes
Table 168. Sinotrans Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 169. Sinotrans Limited Recent Developments
Table 170. Shenzhen SINO-MD Information Technology Co., Ltd. Corporation Information
Table 171. Shenzhen SINO-MD Information Technology Co., Ltd. Description and Major Businesses
Table 172. Shenzhen SINO-MD Information Technology Co., Ltd. Product Features and Attributes
Table 173. Shenzhen SINO-MD Information Technology Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 174. Shenzhen SINO-MD Information Technology Co., Ltd. Recent Developments
Table 175. Technologies, Platforms and Infrastructure
Table 176. Distributors List
Table 177. Market Trends and Market Evolution
Table 178. Market Drivers and Opportunities
Table 179. Market Challenges, Risks, and Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List of Figures
Figure 1. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Barcode/2D Code Product Picture
Figure 3. RFID Product Picture
Figure 4. Hybrid Identification Product Picture
Figure 5. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Deployment Model, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Cloud-Based Product Picture
Figure 7. On-Premises Product Picture
Figure 8. Hybrid Product Picture
Figure 9. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Annual Serialized Units, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Low Annual Serialized Units(≤10 million units) Product Picture
Figure 11. Medium Annual Serialized Units(10 million units<Annual Serialized Units≤100 million units) Product Picture
Figure 12. High Annual Serialized Units(>100 million units) Product Picture
Figure 13. Global Pharmaceutical Track and Trace Solutions Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Serialization and Coding
Figure 15. Supply Chain Traceability
Figure 16. Recall and Verification
Figure 17. Other
Figure 18. Pharmaceutical Track and Trace Solutions Report Years Considered
Figure 19. Global Pharmaceutical Track and Trace Solutions Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 21. Global Pharmaceutical Track and Trace Solutions Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share Ranking (2025)
Figure 24. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 25. Barcode/2D Code Revenue-Based Market Share by Player in 2025
Figure 26. RFID Revenue-Based Market Share by Player in 2025
Figure 27. Hybrid Identification Revenue-Based Market Share by Player in 2025
Figure 28. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Type (2021-2032)
Figure 29. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Deployment Model (2021-2032)
Figure 30. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Annual Serialized Units (2021-2032)
Figure 31. Global Pharmaceutical Track and Trace Solutions Revenue-Based Market Share by Application (2021-2032)
Figure 32. North America Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 33. North America Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 34. North America Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 35. US Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 36. Canada Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 37. Mexico Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 38. Europe Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 39. Europe Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 40. Europe Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 41. Germany Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 42. France Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 43. U.K. Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 44. Italy Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 45. Russia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 46. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 47. Asia-Pacific Top 8 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 48. Asia-Pacific Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 49. Indonesia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 50. Japan Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 51. South Korea Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 52. Australia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 53. India Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 54. Indonesia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 55. Vietnam Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 56. Malaysia Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 57. Philippines Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 58. Singapore Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 59. Central and South America Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 60. Central and South America Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 61. Central and South America Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 62. Brazil Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 63. Argentina Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 64. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue YoY (US$ Million), 2021-2032
Figure 65. Middle East and Africa Top 5 Players Pharmaceutical Track and Trace Solutions Revenue (US$ Million) in 2025
Figure 66. Middle East and Africa Pharmaceutical Track and Trace Solutions Revenue (US$ Million) by Application (2021-2032)
Figure 67. GCC Countries Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 68. Israel Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 69. Egypt Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 70. South Africa Pharmaceutical Track and Trace Solutions Revenue (US$ Million), 2021-2032
Figure 71. Pharmaceutical Track and Trace Solutions Value Chain Mapping
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/20 10:25

160.51 円

176.53 円

212.83 円

ページTOPに戻る